NATIONAL VENTURE CAPITAL ASSOCIATION for NATIONAL VENTURE CAPITAL ASSOCIATION

Energy/Nuclear ENG

Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2015 Energy ad Water Appropriations. Senate Finance Energy Tax Paper.

Contacted: Federal Communications Commission (FCC); Food & Drug Administration (FDA); SENATE; White House Office; Securities & Exchange Commission (SEC); Treasury, Dept of; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2609 (113th)

Banking BAN

Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act.

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); SENATE; Federal Communications Commission (FCC); Treasury, Dept of

Copyright/Patent/Trademark CPT

HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.

Contacted: White House Office; Securities & Exchange Commission (SEC); Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Federal Communications Commission (FCC)

Bills named: S. 866 (113th), S. 1612 (113th), H.R. 3309 (113th), S. 1720 (113th), S. 1013 (113th)

Immigration IMM

HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act.

Contacted: SENATE; Federal Communications Commission (FCC); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); White House Office

Bills named: H.R. 2131 (113th), H.R. 4178 (113th), S. 189 (113th)

Science/Technology SCI

Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act).

Contacted: HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); SENATE; Food & Drug Administration (FDA); White House Office; Treasury, Dept of; Federal Communications Commission (FCC)

Bills named: H.R. 2981 (113th)

Taxation/Internal Revenue Code TAX

S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.

Contacted: HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); White House Office; Federal Communications Commission (FCC); SENATE; Treasury, Dept of; Food & Drug Administration (FDA)

Bills named: S. 232 (113th), H.R. 523 (113th), H.R. 1295 (113th)

Telecommunications TEC

HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".

Contacted: Treasury, Dept of; Food & Drug Administration (FDA); Federal Communications Commission (FCC); HOUSE OF REPRESENTATIVES; White House Office; Securities & Exchange Commission (SEC); SENATE

Bills named: H.R. 1468 (113th), S. 21 (113th), H.R. 624 (113th)

Health Issues HCR

No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill #: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.

Contacted: SENATE; Food & Drug Administration (FDA); Federal Communications Commission (FCC); White House Office; Treasury, Dept of; HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC)

Bills named: S. 2389 (113th), H.R. 4800 (113th), H.R. 4302 (113th)